Immunogenicity	B:C4054739
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	B:C1707887
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	B:C0085957
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	B:C0026912
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	B:C0003320
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	B:C0675617
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	B:C1506203
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	B:C1744314
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	B:C0079460
-	I:C0079460
CSF	I:C0079460
and	O
IL	O
-	I:C0123759
12p70	I:C0123759
.	O

Immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
Bacille	O
Calmette	I:C0085957
-	I:C0085957
Guerin	I:C0085957
strains	O
expressing	O
mycobacterium	O
antigens	O
Ag85A	O
,	O
CFP10	O
,	O
ESAT	O
-6	I:C1744314
,	O
GM	O
-	I:C0079460
CSF	I:C0079460
and	O
IL	B:C0123759
-	I:C0123759
12p70	I:C0123759
.	O

This	O
study	B:C2603343
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	B:C0220825
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	B:C4054739
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	B:C1707887
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	B:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	B:C0085957
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	B:C0675617
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	B:C0675617
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	B:C1506203
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	B:C1506203
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	B:C1744314
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	B:C1744314
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	B:C0123759
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	B:C0123759
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	B:C0162768
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	B:C0079460
-	I:C0079460
CSF	I:C0079460
(	O
G	O
)	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
immunogenicity	O
and	O
protective	O
efficacy	O
of	O
recombinant	O
bacille	O
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
(	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
)	O
strains	O
expressing	O
Ag85A	O
(	O
A	O
)	O
,	O
CFP10	O
(	O
C	O
)	O
,	O
ESAT6	O
(	O
E	O
)	O
,	O
IL	O
-	I:C0123759
12p70	I:C0123759
(	O
I	O
)	O
,	O
and	O
fusion	O
protein	I:C0162768
GM	O
-	I:C0079460
CSF	I:C0079460
(	O
G	B:C0079460
)	O
.	O

rBCGs	B:C0085957
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	B:C0675617
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	B:C1506203
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	B:C1744314
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	B:C0123759
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	B:C0079460
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	B:C3181051
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	B:C0162768
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	B:C0162768
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	B:C0162768
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	B:C0162768
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	B:C0162768
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	B:C0085957
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	O
-	I:C0085957
SH	I:C0085957
.	O

rBCGs	O
were	O
established	O
by	O
integrating	O
of	O
A	O
,	O
C	O
,	O
E	O
,	O
I	O
,	O
G	O
,	O
AE	O
,	O
CE	O
,	O
IE	O
,	O
GC	O
,	O
GE	O
and	O
GCE	O
into	O
Mycobacterium	O
bovis	I:C0085957
BCG	I:C0085957
-	I:C0085957
1173	I:C0085957
and	O
BCG	B:C0085957
-	I:C0085957
SH	I:C0085957
.	O

The	O
macro-	O
effects	O
of	O
rBCGs	B:C0085957
on	O
mice	O
were	O
evaluated	O
by	O
phenotype	O
and	O
weight	O
.	O

The	O
macro-	O
effects	O
of	O
rBCGs	O
on	O
mice	B:C0025929
were	O
evaluated	O
by	O
phenotype	O
and	O
weight	O
.	O

The	O
macro-	O
effects	O
of	O
rBCGs	O
on	O
mice	O
were	O
evaluated	B:C0220825
by	O
phenotype	O
and	O
weight	O
.	O

The	O
immunogenicity	B:C4054739
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	B:C0085957
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	B:C2754943
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	B:C2754944
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	B:C2754946
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	B:C0021745
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	B:C0021758
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	B:C0014441
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

The	O
immunogenicity	O
of	O
rBCGs	O
was	O
analyzed	O
by	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
antibody	I:C2754946
titers	O
,	O
and	O
IFN	O
-γ	I:C0021745
and	O
IL	O
-	I:C0021758
4	I:C0021758
contents	O
through	O
Enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
(	O
Enzyme	B:C0014441
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
)	O
.	O

Meanwhile	O
,	O
the	O
proportions	O
of	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215
and	O
CD8	O
(+	I:C0242629
)	I:C0242629

Meanwhile	O
,	O
the	O
proportions	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
and	O
CD8	B:C0242629
(+	I:C0242629
)	I:C0242629

T	I:C0242629
splenic	I:C0242629
lymphocytes	I:C0242629
were	O
determined	O
using	O
flow	B:C0016263
cytometry	I:C0016263
.	O

The	O
protective	O
efficacy	B:C1707887
of	O
rBCGs	O
was	O
evaluated	O
by	O
bacterial	O
load	O
in	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
immunized	O
mice	O
.	O

The	O
protective	O
efficacy	O
of	O
rBCGs	B:C0085957
was	O
evaluated	O
by	O
bacterial	O
load	O
in	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
immunized	O
mice	O
.	O

The	O
protective	O
efficacy	O
of	O
rBCGs	O
was	O
evaluated	B:C0220825
by	O
bacterial	O
load	O
in	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
immunized	O
mice	O
.	O

The	O
protective	O
efficacy	O
of	O
rBCGs	O
was	O
evaluated	O
by	O
bacterial	O
load	O
in	O
spleen	B:C0771377
and	O
lung	O
tissues	I:C0819757
from	O
immunized	O
mice	O
.	O

The	O
protective	O
efficacy	O
of	O
rBCGs	O
was	O
evaluated	O
by	O
bacterial	O
load	O
in	O
spleen	O
and	O
lung	B:C0819757
tissues	I:C0819757
from	O
immunized	O
mice	O
.	O

The	O
protective	O
efficacy	O
of	O
rBCGs	O
was	O
evaluated	O
by	O
bacterial	O
load	O
in	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
immunized	O
mice	B:C0025929
.	O

rBCGs	B:C0085957
exhibited	O
no	O
obvious	O
side	O
effects	I:C0879626
on	O
mice	O
.	O

rBCGs	O
exhibited	O
no	O
obvious	O
side	B:C0879626
effects	I:C0879626
on	O
mice	O
.	O

rBCGs	O
exhibited	O
no	O
obvious	O
side	O
effects	I:C0879626
on	O
mice	B:C0025929
.	O

The	O
antibody	B:C0003241
titers	O
of	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
,	O
proportion	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
and	O
CD8	O
(+)	I:C0242629

The	O
antibody	O
titers	O
of	O
lgG	B:C2754943
,	O
lgG1	O
and	O
lgG2a	O
,	O
proportion	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
and	O
CD8	O
(+)	I:C0242629

The	O
antibody	O
titers	O
of	O
lgG	O
,	O
lgG1	B:C2754944
and	O
lgG2a	O
,	O
proportion	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
and	O
CD8	O
(+)	I:C0242629

The	O
antibody	O
titers	O
of	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	B:C2754946
,	O
proportion	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
and	O
CD8	O
(+)	I:C0242629

The	O
antibody	O
titers	O
of	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
,	O
proportion	O
of	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215
and	O
CD8	O
(+)	I:C0242629

The	O
antibody	O
titers	O
of	O
lgG	O
,	O
lgG1	O
and	O
lgG2a	O
,	O
proportion	O
of	O
CD4	O
(+	I:C0039215
)	I:C0039215
and	O
CD8	B:C0242629
(+)	I:C0242629

T	I:C0242629
cells	I:C0242629
,	O
and	O
concentrations	O
of	O
IFN	B:C0021745
-γ	I:C0021745
were	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
that	O
in	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
(	O
P	O
<	O
0.05	O
)	O
.	O

T	I:C0242629
cells	I:C0242629
,	O
and	O
concentrations	O
of	O
IFN	O
-γ	I:C0021745
were	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
multiple	O
-	O
gene	B:C0017337
rBCGs	O
than	O
that	O
in	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
(	O
P	O
<	O
0.05	O
)	O
.	O

T	I:C0242629
cells	I:C0242629
,	O
and	O
concentrations	O
of	O
IFN	O
-γ	I:C0021745
were	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
multiple	O
-	O
gene	O
rBCGs	B:C0085957
than	O
that	O
in	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
(	O
P	O
<	O
0.05	O
)	O
.	O

T	I:C0242629
cells	I:C0242629
,	O
and	O
concentrations	O
of	O
IFN	O
-γ	I:C0021745
were	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
that	O
in	O
single	B:C0017337
-	I:C0017337
gene	I:C0017337
rBCGs	O
(	O
P	O
<	O
0.05	O
)	O
.	O

T	I:C0242629
cells	I:C0242629
,	O
and	O
concentrations	O
of	O
IFN	O
-γ	I:C0021745
were	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
that	O
in	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	B:C0085957
(	O
P	O
<	O
0.05	O
)	O
.	O

Bacterial	O
load	O
in	O
both	O
spleen	B:C0771377
and	O
lung	O
tissues	I:C0819757
from	O
mice	O
infected	O
with	O
M.	O
tuberculosis	I:C1449831
H37Rv	I:C1449831
were	O
significantly	O
reduced	O
by	O
rBCGs	O
.	O

Bacterial	O
load	O
in	O
both	O
spleen	O
and	O
lung	B:C0819757
tissues	I:C0819757
from	O
mice	O
infected	O
with	O
M.	O
tuberculosis	I:C1449831
H37Rv	I:C1449831
were	O
significantly	O
reduced	O
by	O
rBCGs	O
.	O

Bacterial	O
load	O
in	O
both	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
mice	B:C0025929
infected	O
with	O
M.	O
tuberculosis	I:C1449831
H37Rv	I:C1449831
were	O
significantly	O
reduced	O
by	O
rBCGs	O
.	O

Bacterial	O
load	O
in	O
both	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
mice	O
infected	B:C0439663
with	O
M.	O
tuberculosis	I:C1449831
H37Rv	I:C1449831
were	O
significantly	O
reduced	O
by	O
rBCGs	O
.	O

Bacterial	O
load	O
in	O
both	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
mice	O
infected	O
with	O
M.	B:C1449831
tuberculosis	I:C1449831
H37Rv	I:C1449831
were	O
significantly	O
reduced	O
by	O
rBCGs	O
.	O

Bacterial	O
load	O
in	O
both	O
spleen	O
and	O
lung	O
tissues	I:C0819757
from	O
mice	O
infected	O
with	O
M.	O
tuberculosis	I:C1449831
H37Rv	I:C1449831
were	O
significantly	O
reduced	O
by	O
rBCGs	B:C0085957
.	O

A	O
significantly	O
lower	O
bacterial	O
load	O
was	O
revealed	O
in	O
recombinant	B:C0085957
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
-	O
1173	O
:	O
A	O
compared	O
with	O
multiple	O
-	O
gene	O
rBCGs	O
(	O
P	O
<	O
0.05	O
)	O
.	O

A	O
significantly	O
lower	O
bacterial	O
load	O
was	O
revealed	O
in	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
-	O
1173	O
:	O
A	O
compared	O
with	O
multiple	O
-	O
gene	B:C0017337
rBCGs	O
(	O
P	O
<	O
0.05	O
)	O
.	O

A	O
significantly	O
lower	O
bacterial	O
load	O
was	O
revealed	O
in	O
recombinant	O
bacille	I:C0085957
calmette	I:C0085957
-	I:C0085957
guerin	I:C0085957
-	O
1173	O
:	O
A	O
compared	O
with	O
multiple	O
-	O
gene	O
rBCGs	B:C0085957
(	O
P	O
<	O
0.05	O
)	O
.	O

Immunogenicity	B:C4054739
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	B:C0017337
rBCGs	O
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	B:C0085957
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
on	O
single	B:C0017337
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	B:C0085957
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	B:C1707887
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	B:C0085957
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	O
-	I:C0085957
1173	I:C0085957
.	O

Immunogenicity	O
was	O
better	O
on	O
multiple	O
-	O
gene	O
rBCGs	O
than	O
on	O
single	O
-	I:C0017337
gene	I:C0017337
rBCGs	O
,	O
while	O
excellent	O
protective	O
efficacy	O
was	O
exhibited	O
on	O
rBCG	O
-	I:C0085957
1173:	I:C0085957
A	I:C0085957
and	O
BCG	B:C0085957
-	I:C0085957
1173	I:C0085957
.	O

